Phase 1 Trial of the TQB2928 Injection in Patients With Advanced Cancers

Clinical trial NCT04854681 · UNKNOWN

Trial details

NCT number: NCT04854681
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors and Hematological Malignancies

Start date: 2021-08-01
Primary completion: 2022-07-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.